US$ 20.68
hot flashes on glp 1 Ozempic and Menopause: The Truth About GLP-1 Drugs for Weight Loss — Hello, Flash Potential New GLP-1 Side Effects
Description
At 72 weeks, tirzepatide beat semaglutide on both the primary endpoint and all five key secondary endpoints

The results were a total of 218 RCTs (339 arms and 77 950 patients) met the inclusion criteria

About 95%+ of plans cover GLP-1s for type 2 diabetes

Specific safety considerations under investigation include the long-term effects of sustained glucagon receptor activation
I think GLP-1s, and what we really know about them, is still kind of in its infancy, said Dr

Sarath Chandran (MD DVL)
